Sage Journals: Discover world-class research

Retricted access

Research article

First published 2015-7

An Evaluation of the Efficiency of the Gulf Cooperation Council’s Centralized Procedure by the Gulf Regulatory Authorities and Pharmaceutical Companies

Mohamed H. Al-Rubaie, Sam Salek, Stuart Walker

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2009-8

Opportunities and Challenges in an Ever Generic World

Alan Sheppard

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Retricted access

Research article

First published 1999-06

Impact of centralization of cytotoxic drug preparations

Delphine Cabelguenne, Christine Pivot-Dumarest, Eliane Vermeulen

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2026

Management of medication errors in oncological patients: A cross-sectional study and case reports of pharmaceutical interventions in a university hospital in central-west Brazil

Esther Domenici Mozzer Pontes, Renato Rocha Martins, Paulo Augusto Souza Fernandes [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 1982-10

Central Patents Index (CPI) as a Source of Information for the Pharmaceutical Chemist

P. Norton

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 1996-4

What Can be Learned from Experience Gained using the Old European Concertation Procedure?

Christopher Parkinson, Cynthia E. Lumley

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 1994-4

Managing Medical Coding of Safety Data within a Multinational Corporation

Elizabeth N. Clark, Diane M. Geer

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2008-1

Strengthening Corporate Social Responsibility in the Pharmaceutical Industry

Diego Esteban

Journal of Medical Marketing: Device,Diagnostic and Pharmaceutical Marketing

Retricted access

Research article

First published 2024-4

Sick with “shareholder value”: US pharma’s financialized business model during the pandemic

William Lazonick, Öner Tulum

Competition & Change

Retricted access

Research article

First published 2014-5

Global Pharmaceutical and Biotechnology Firms’ Linkages in the World City Network

Stefan Krätke

Urban Studies

Search results